Epidemiological Analysis and Geographical Distribution of Patients Suffering from Rheumatoid Arthritis, Eligible for First-Line Therapy/Monotherapy Treatment with Subcutaneous Formulation of Tocilizumab in the Republic of Macedonia Cover

.blurhash-client-img { display: none !important; }

Epidemiological Analysis and Geographical Distribution of Patients Suffering from Rheumatoid Arthritis, Eligible for First-Line Therapy/Monotherapy Treatment with Subcutaneous Formulation of Tocilizumab in the Republic of Macedonia

Volume 39 (2018): Issue 2-3 (December 2018)

By: Filip Gucev, Snezana Perchinkova-Mishevska, Georgi Bozinovski, Irena Kafedjiska, Dubravka Antova, Ljubinka Damjanovska-Krstic, Bashkim Osmani, Fjola Hadjihamza and Oliver Nikolov

Open Access

|Dec 2018

DOI: https://doi.org/10.2478/prilozi-2018-0044 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345

Journal RSS Feed

Language: English

Page range: 69 - 78

Published on: Dec 31, 2018

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Rheumatoid arthritis,

first-line treatment/monotherapy,

Related subjects:

Basic medical science,

History and ethics of medicine,

Clinical medicine,

Clinical medicine, other,

Social sciences,

Education, other

© 2018 Filip Gucev, Snezana Perchinkova-Mishevska, Georgi Bozinovski, Irena Kafedjiska, Dubravka Antova, Ljubinka Damjanovska-Krstic, Bashkim Osmani, Fjola Hadjihamza, Oliver Nikolov, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 39 (2018): Issue 2-3 (December 2018)Next article